CAPRI Registry for Juvenile Idiopathic Arthritis
CAPRI National Juvenile Idiopathic Arthritis Registry
Recruiting
Observational Study
Juvenile Idiopathic Arthritis (JIA)
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- Up to 18
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,238 (estimated)
- Sponsor
- University of British Columbia · Other
Who this trial is looking for
This trial is looking for children who have been recently diagnosed with Juvenile Idiopathic Arthritis (JIA). Participants will help collect important information about the disease and its treatment.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with Juvenile Idiopathic Arthritis in the last 3 months.
- I participated in the original ReACCh-Out study.
- I completed my two-year follow-up in the LEAP study.
You may not be able to join if
- I have not been confirmed to have Juvenile Idiopathic Arthritis.
- I was diagnosed with Juvenile Idiopathic Arthritis more than 3 months ago and was not followed in LEAP or ReACCh-Out.
- My family cannot answer questionnaires in English or French.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Juvenile Idiopathic Arthritis (JIA) is a disorder of unknown cause characterized by chronic inflammation of the joints and other organs. It affects about 1 in a 1000 Canadian children and if untreated it can produce lifelong disability. The Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI) includes most pediatric rheumatologists in Canada. They have successfully collaborated for th…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. All patients newly diagnosed with JIA within the last 3 months
2. All patients who participated in the original ReACCh-Out study
3. LEAP study patients from 'newly diagnosed' and 'ReACCh-Out' cohorts who have completed their two year follow up in LEAP
Exclusion Criteria:
1.…
Contacts